Skip to main content
SpringerLink
Log in

Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colorectal Cancer

  • SSAT State-of-the-Art Conference
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Colorectal cancer develops and progresses from genetic and genomic changes that occur within and transforms the growth behavior of a normal colonic cell. Molecular tools have advanced enough to allow the scientific community to probe deeper into risk alleles within a population as well as into individual patient genetic data that can ascribe such a risk. Detected genetic and genomic changes from colorectal cancer can help determine a patient’s prognosis, predict response to chemotherapy, and determine the approach to care with biological therapies. Utilizing stool, blood/plasma, and tumor tissue to obtain genetic, genomic, and pharmacokinetic information contribute to a person’s profile to direct specific cancer care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.

    Article  PubMed  CAS  Google Scholar 

  2. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science. 1989;244:207–11.

    Article  PubMed  CAS  Google Scholar 

  3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85.

    Article  PubMed  CAS  Google Scholar 

  4. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079–99.

    Article  PubMed  CAS  Google Scholar 

  5. Boland CR, Sinicrope FA, Brenner DE, Carethers JM. Colorectal cancer prevention and treatment. Gastroenterology. 2000;118:S115–28.

    Article  PubMed  CAS  Google Scholar 

  6. Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR. Use of 5-fluorouracil and survival in patients with microsatellite unstable colorectal cancer. Gastroenterology. 2004;126: 394–401.

    Article  PubMed  CAS  Google Scholar 

  7. Carethers JM. Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor. Therap Adv Gastroenterol. 2008;1:33–42.

    Article  PubMed  Google Scholar 

  8. Carethers JM, Hawn MT, Chauhan DP, Luce MC, Marra G, Koi M, Boland CR. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine. J Clin Invest 1996;98:199–206.

    Article  PubMed  CAS  Google Scholar 

  9. Clark-Langone KM, Sangli C, Krishnakumar J, Watson D. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the oncotype DX colon cancer assay. BMC Cancer. 2010;10:691.

    Article  PubMed  CAS  Google Scholar 

  10. Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, Howell SB, Boland CR. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology. 1999;117:123–131.

    Article  PubMed  CAS  Google Scholar 

  11. Papouli E, Cejka P, Jiricny J. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res 2004;64:3391–3394.

    Article  PubMed  CAS  Google Scholar 

  12. Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology 2004;127:1678–84.

    Article  PubMed  CAS  Google Scholar 

  13. Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, Boothman DA. DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 2005;280:5516–13

    Article  PubMed  CAS  Google Scholar 

  14. Arnold CN, Goel A, Boland CR. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer. 2003;106:66–73.

    Article  PubMed  CAS  Google Scholar 

  15. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247–257.

    Article  PubMed  CAS  Google Scholar 

  16. Jover R, Zapater P, Castells A, Llor X, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006;55:848–855.

    Article  PubMed  CAS  Google Scholar 

  17. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

    Article  PubMed  CAS  Google Scholar 

  18. Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer. 2009;115:3609–17.

    Article  PubMed  CAS  Google Scholar 

  19. Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010;15:390–404.

    Article  PubMed  CAS  Google Scholar 

  20. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60:116–29.

    Article  PubMed  CAS  Google Scholar 

  21. McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl J Med. 2011;364:340–50.

    Article  PubMed  CAS  Google Scholar 

  22. Carethers JM. Should African Americans be screened for colorectal cancer at an earlier age? Nat Clin Pract Gastroenterol Hepatol. 2005;2:352–3.

    Article  PubMed  Google Scholar 

  23. Nambiar PR, Gupta RR, Misra V. An "Omics" based survey of human colon cancer. Mutat Res. 2010;693:3–18.

    Article  PubMed  CAS  Google Scholar 

  24. Ma Y, Ding Z, Qian Y, Shi X, Castranova V, Harner EJ, Guo L. Predicting cancer drug response by proteomic profiling. Clin Cancer Res. 2006;12:4583–9.

    Article  PubMed  CAS  Google Scholar 

  25. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep. 2008;10:396–403.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The contents of this article were presented at the annual meeting of the Society for Surgery of the Alimentary Tract during Digestive Diseases Week, May 8, 2011, in Chicago, IL, USA. Supported by the US Public Health Service (DK067287) and the SDSU/UCSD Comprehensive Cancer Center Partnership (CA132379 and CA132384).

Conflicts of interest

There are no conflicts of interest for the author.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Internal Medicine, University of Michigan, 3901 Taubman Center, SPC 5368, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109-5368, USA

    John M. Carethers

Authors
  1. John M. Carethers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Carethers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carethers, J.M. Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colorectal Cancer. J Gastrointest Surg 16, 1648–1650 (2012). https://doi.org/10.1007/s11605-012-1942-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-012-1942-2

Keywords

Search

Navigation